Navigation Links
Tunnell Consulting to Partner with Pharma Quality and Compliance Expert Dr. Ali Afnan
Date:1/22/2013

King of Prussia, PA (PRWEB) January 22, 2013

Tunnell Consulting, Inc. today announced that it has formed a partnership with Ali Afnan, PhD, President of Step Change Pharma, a life sciences consultancy working at the intersection of regulatory compliance and pharmaceutical science.

An expert in compliance and quality, Dr. Afnan was recruited in 2003 by the FDA’s Center for Drug Evaluation and Research (CDER) to join the agency’s Process Analytical Technology (PAT) and Drug Product Quality initiatives. As a member of the PAT steering team and as the science policy advisor to the Office of Pharmaceutical Science, he co-authored the agency’s PAT Guidance and helped draft its most recent guidance on process validation.

“Dr. Afnan’s experience at the FDA enables him to provide life sciences clients with an invaluable perspective on technical and regulatory compliance matters. His demonstrated expertise in compliance, Quality by Design and pharmaceutical science complements Tunnell’s longstanding strengths in those critical areas,” said Conrad J. Heilman, Jr., PhD, President and CEO of Tunnell. “As partners, our combined technical skills and regulatory compliance knowledge will offer both Tunnell and Step Change clients’ unparalleled resources for achieving excellence in their operations.”

“I am delighted to partner with Tunnell, with its proven methodologies and long track record of delivering sustainable solutions to leading pharmaceutical companies,” said Dr. Afnan. “Together we will be able to h
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
2. A leading Massachusetts-based IT and Life Sciences staffing and consulting firm has opened two new offices in the Ohio Valley
3. No on Prop. 37: French Rat Study Author Made Reporters Sign Confidentiality Agreements Prohibiting them from Consulting Independent Scientific Experts
4. EAS Consulting Group Realigns Its Management for Growth
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
7. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
8. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
9. Pittcon and Food Safety Tech Announce Strategic Conference Partnership
10. Direct Marketing Partners Wins Sales Lead Management’s “Most Influential” in 2012
11. RegLink News Partners with FOI Services on Off-Label Use Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 26, 2015  23andMe, the leading personal genetics company, ... as Privacy Officer and Corporate Counsel. Black brings a ... as well as health care regulations. As a member ... responsible for reviewing, updating and enhancing the company,s privacy ... abroad. She joined the company January 5, 2015 and ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... Bio Inc. (ORC) a biotech company developing stem ... with the European Competent Authority in Seville, Spain, ... HYC750 in healthy male volunteers. The goal of ... pharmacokinetics and pharmacodynamics (induction of hematopoiesis) of HYC750, ...
... SHENYANG, China, Feb. 9 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... focused on researching,developing, manufacturing and marketing biopharmaceutical products ... Mr. Bo Tan as Chief Financial,Officer, effective February ... Mr.,Tan has been acting as the financial advisor ...
... DUBLIN, Ireland, February 9, Shire plc (LSE: SHP, NASDAQ: ... IV Notice letters from Barr Laboratories, Inc.,("Barr) and Mylan, ... in each case of the filing of an Abbreviated ... 750mg and 1gm FOSRENOL(R),(lanthanum carbonate). , ...
Cached Biology Technology:Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 33SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 2Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2
(Date:2/23/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... payment method. Payment accounts may be selected via voice ... if both the speech (the word associated with the ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... and doctors from universities and industries around the ... project announced Sept. 4 to develop implantable devices ... designed to adapt to physical changes in a ... Naturally dissolving plates, screws, stents, and other devices ...
... 2008 As the anniversary of the September 11 ... a new podcast describing an array of technologies to ... podcast is the sixth episode in ACS,s acclaimed ... twice monthly, Global Challenges examines daunting problems facing society ...
... a gene enhancer, known as HACNS1, that may have contributed ... possibly also modifications in the ankle or foot that allow ... published in Science on Sept. 5, 2008. ... existence of human-specific gene enhancers, which are switches near genes ...
Cached Biology News:Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 2Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 3Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 4New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
... BODIPY FL ATP-Gamma-S binds to ... nucleotide the BODIPY FL fluorophore was ... In addition to its potential use ... ATP-Gamma-S thioether is an important new ...
... the industry standard microarray image analysis software ... and analysis tools, visualizations, automation capabilities, performance ... included with every GenePix scanner, and it ... and all types of arrays. A wide ...
... Simplify the process and you reduce the ... into the CEQ 8000. Developed using Beckman ... leadership in capillary electrophoresis technology, the CEQ ... system. This system automatically fills the capillary ...
Biology Products: